| First Author | Duque G | Year | 2011 |
| Journal | J Bone Miner Res | Volume | 26 |
| Issue | 7 | Pages | 1472-83 |
| PubMed ID | 21308779 | Mgi Jnum | J:233116 |
| Mgi Id | MGI:5780796 | Doi | 10.1002/jbmr.350 |
| Citation | Duque G, et al. (2011) Interferon-gamma plays a role in bone formation in vivo and rescues osteoporosis in ovariectomized mice. J Bone Miner Res 26(7):1472-83 |
| abstractText | Interferon gamma (IFN-gamma) is a cytokine produced locally in the bone microenvironment by cells of immune origin as well as mesenchymal stem cells. However, its role in normal bone remodeling is still poorly understood. In this study we first examined the consequences of IFN-gamma ablation in vivo in C57BL/6 mice expressing the IFN-gamma receptor knockout phenotype (IFNgammaR1(-/-)). Compared with their wild-type littermates (IFNgammaR1(+/+)), IFNgammaR1(-/-) mice exhibit a reduction in bone volume associated with significant changes in cortical and trabecular structural parameters characteristic of an osteoporotic phenotype. Bone histomorphometry of IFNgammaR1(-/-) mice showed a low-bone-turnover pattern with a decrease in bone formation, a significant reduction in osteoblast and osteoclast numbers, and a reduction in circulating levels of bone-formation and bone-resorption markers. Furthermore, administration of IFN-gamma (2000 and 10,000 units) to wild-type C57BL/6 sham-operated (SHAM) and ovariectomized (OVX) female mice significantly improved bone mass and microarchitecture, mechanical properties of bone, and the ratio between bone formation and bone resorption in SHAM mice and rescued osteoporosis in OVX mice. These data therefore support an important physiologic role for IFN-gamma signaling as a potential new anabolic therapeutic target for osteoporosis. |
